Industry Update: Clinical Research Organizations

Industry Highlights

  • On December 10, 2020, Syneos Health® announced that it had completed the previously announced acquisition of Synteract, a leading full-service CRO focused on the rapidly growing, emerging biopharma segment for approximately $400 million. Synteract’s multidisciplinary teams support biotech and pharmaceutical companies across all phases of drug development, providing deep expertise in oncology, dermatology, general medicine, infectious disease, and vaccines.
  • On December 18, 2020, Syneos Health, the only fully integrated biopharmaceutical solutions organization, announced the acquisition of Illingworth Research Group™, a leading provider of clinical research home health services. With healthcare already becoming more local, COVID-19 has accelerated the need for in-home clinical trial services.

Past Industry Updates

More Industry Reports